We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
-47.15%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
10 Year Est. Return
AUM
$128M
AUM Growth
Cap. Flow
+$261M
Cap. Flow %
203.62%
Top 10 Hldgs %
97.32%
Holding
12
New
12
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
IVVD icon
Invivyd
IVVD
+$147M
2
BBIO icon
BridgeBio Pharma
BBIO
+$19.7M
3
WVE icon
Wave Life Sciences
WVE
+$15.6M
4
CRIS icon
Curis
CRIS
+$15.5M
5
TGTX icon
TG Therapeutics
TGTX
+$13.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.47%
2 Financials 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
1
Invivyd
IVVD
$180M
$41.1M 32.12%
+5,665,221
New +$147M
STOK icon
2
Stoke Therapeutics
STOK
$1.82B
$12.6M 9.87%
+527,150
New +$12.6M
CRIS icon
3
Curis
CRIS
$9.53M
$12.4M 9.7%
+6,522
New +$15.5M
WVE icon
4
Wave Life Sciences
WVE
$1.12B
$11.8M 9.23%
+3,765,588
New +$15.6M
RCKT icon
5
Rocket Pharmaceuticals
RCKT
$348M
$10.8M 8.44%
+495,280
New +$13.5M
TGTX icon
6
TG Therapeutics
TGTX
$8.58B
$10M 7.82%
+527,000
New +$13.7M
BBIO icon
7
BridgeBio Pharma
BBIO
$16.5B
$7.78M 6.07%
+466,200
New +$19.7M
NKTR icon
8
Nektar Therapeutics
NKTR
$2.39B
$7.57M 5.91%
+37,373
New +$8.11M
ATRA icon
9
Atara Biotherapeutics
ATRA
$71.2M
$7.2M 5.62%
+18,275
New +$7.69M
CYPH
10
Cypherpunk Technologies Inc
CYPH
$66.2M
$3.24M 2.53%
+100,000
New +$2.78M
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.82M 2.2%
+19,200
New +$2.98M
NEXI
12
DELISTED
NexImmune, Inc. Common Stock
NEXI
$615K 0.48%
+5,338
New +$1.28M

Similar funds

M28 Capital Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for M28 Capital Management, which disclosed 12 positions worth $128M. Its ten largest holdings account for 97% of the portfolio.

Its largest position is Invivyd: 5,665,221 shares worth $41.1M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, followed by Financials.

  • M28 Capital Management's largest Q4 2021 buy was Invivyd: 5,665,221 shares worth $41.1M.
  • M28 Capital Management's ten largest holdings make up 97% of its $128M portfolio in Q4 2021.
  • M28 Capital Management disclosed 12 positions in Q4 2021, its first 13F filing on record.

Based on M28 Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.